Observational study on the effectiveness of the medical device "Beurer EM 50 Menstrual Relax" in reducing menstrual pain associated with primary dysmenorrhoea (ReduPain)

Observational study on the effectiveness of the medical device "Beurer EM 50 Menstrual Relax" in reducing menstrual pain associated with primary dysmenorrhoea (ReduPain) - ReduPain

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024411

Enrollment

Registered

2021-06-15

Start date

2021-06-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N94.4

Interventions

Group 1: Patients with menstrual pain Evaluate the effect and handling of the "Beurer EM 50 Menstrual Relax" device during menstruation using questionnaires.

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Willingness to participate in the study (Informed consent) - Older than 18 years - Premenopausal - Primary dysmenorrhoea, in the lower abdomen. (VAS = 25) - Menstruation in the last 6 weeks with a cycle length of 3 to 6 weeks.

Exclusion criteria

Exclusion criteria: - Known pregnancy - Abdominal surgery in the last 6 months before study inclusion - Injuries or exanthema of the abdominal wall - Known allergies to the plastic of the EM50 - Wearing non-removable piercings - Wearing an intrauterine device (IUD)

Design outcomes

Primary

Measure	Time frame
Average intraindividual improvement in pain score after use of the device on day 1, 2 and 3	—

Secondary

Measure	Time frame
Average intraindividual improvement in pain score after use of the device (averages of all measurements) - Duration of pain relief after application of the device - Improvement of pain (VAS McGill), compared to comparison cycle - Restriction of daily life, compared to comparison cycle - Use of pain medication, compared to comparison cycle - Frequency of AEs - Frequency of use of the EM50 - Handling device (one-time day 5)	—

Measure

Time frame

Average intraindividual improvement in pain score after use of the device (averages of all measurements) - Duration of pain relief after application of the device - Improvement of pain (VAS McGill), compared to comparison cycle - Restriction of daily life, compared to comparison cycle - Use of pain medication, compared to comparison cycle - Frequency of AEs - Frequency of use of the EM50 - Handling device (one-time day 5)

—

Countries

Germany

Contacts

Public ContactThomas Kurscheid

Institut Prof. Kurscheid

info@dr-kurscheid.de0221 8004320

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026